Report: Jacoby Ellsbury joins Mike Cameron on DL for Red Sox

0 Comments

The Boston Globe reports that Jacoby Ellsbury will land on the 15-day disabled list nine days after he suffered bruised ribs in a collision with Adrian Beltre while trying to catch a foul popup.
Replacing him on the roster will be veteran Darnell McDonald, who was off to a stellar .341/.372/.683 start in 41 at-bats for Triple-A Pawtucket. The 31-year-old saw time with the Reds last year and hit .267/.306/.400 in 105 at-bats.
Ellsbury’s DL assignment will be backdated, meaning he could return in a week. The Red Sox were hopeful he’d be back by now after two rounds of X-rays found no breaks, but he still feels pain while swinging a bat.
It will be interesting to see whether McDonald or top prospect Josh Reddick plays more in the short-term. Reddick was the choice to replace Mike Cameron on the roster earlier in the day, but he was hitting just .179/.200/.359 for Pawtucket and he’s no better of a defender in center than McDonald. Still, it would make sense for Boston to use the lefty-swinging Reddick against righties and McDonald versus lefties.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
0 Comments

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.